Perspective Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q1 2023 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Perspective Therapeutics, Inc. quarterly Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2023 to Q3 2024.
  • Perspective Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 70.6M shares, a 152% increase year-over-year.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 70.6M +42.6M +152% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 66.6M +38.6M +138% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 495M +267M +117% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q3 2023 28.1M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 28M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 229M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.